NCT06296992 Type 1 Diabetes, Exercise and Mentoring Trial
| NCT ID | NCT06296992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-02-01 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study aims to improve the psychosocial health of adolescents living with type 1 diabetes (T1D). The study will generate knowledge and support knowledge mobilization about the effectiveness of a novel model of care for psychosocial health and self-management for adolescents living with type 1 diabetes (T1D). The novel model of care is the recruitment and training if young adult mentors to deliver a behavioural intervention that empowers adolescents with T1D to increase daily physical activity. The study will also advance the development and implementation of this peer mentoring model to improve the psychosocial health of adolescents with T1D.
Eligibility Criteria
Inclusion Criteria: * want to increase their daily PA * currently use a continuous glucose monitor (CGM) Exclusion Criteria: * were diagnosed with T1D within 12 months of randomization * have diabetes secondary to medications or surgery * have cancer * evidence of drug/alcohol abuse * have an eating disorder * an orthopedic injury or illness that would limit their ability to engage in daily PA * a suicide attempt in the previous 12 months * are pregnant
Contact & Investigator
Jonathan McGavock
PRINCIPAL INVESTIGATOR
University of Manitoba / the Children's Hospital Research Institute of Manitoba
Frequently Asked Questions
Who can join the NCT06296992 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296992 currently recruiting?
Yes, NCT06296992 is actively recruiting participants. Contact the research team at jmcgavock@chrim.ca for enrollment information.
Where is the NCT06296992 trial being conducted?
This trial is being conducted at Winnipeg, Canada, Mississauga, Canada.
Who is sponsoring the NCT06296992 clinical trial?
NCT06296992 is sponsored by University of Manitoba. The principal investigator is Jonathan McGavock at University of Manitoba / the Children's Hospital Research Institute of Manitoba. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.